Generalized weakness resident survival guide: Difference between revisions
Jump to navigation
Jump to search
MoisesRomo (talk | contribs) No edit summary |
MoisesRomo (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated. | Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated. | ||
*[[ | *[[Cadmium poisoning|Cadmium]] [[poisoning]] | ||
*[[ | *[[Dicamba]] [[poisoning]] | ||
*[[ | *[[Fluoride poisoning]] | ||
*[[Hexane-2,5-dione]] [[poisoning]] | |||
*[[Temik]] [[poisoning]] | |||
*[[Benztropine Mesylate Oral (patient information)|Benztropine Mesylate]] [[overdose]] | |||
*[[Hypercalcemia]] | |||
*[[Hyperkalaemic periodic paralysis]] | |||
*[[Hypermagnesemia]] | |||
*[[Hypermethioninemia]] | |||
*[[Hypokalemic periodic paralysis]] | |||
*[[Hypomagnesemia]] | |||
*[[Hypophosphatemia]] | |||
*[[Uremia]] | |||
===Common Causes=== | ===Common Causes=== | ||
Revision as of 00:43, 22 October 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.
Synonyms and Keywords: dystrophy, myasthenia gravis, Guillian-barre syndrome, polymyositis, emg
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- Cadmium poisoning
- Dicamba poisoning
- Fluoride poisoning
- Hexane-2,5-dione poisoning
- Temik poisoning
- Benztropine Mesylate overdose
- Hypercalcemia
- Hyperkalaemic periodic paralysis
- Hypermagnesemia
- Hypermethioninemia
- Hypokalemic periodic paralysis
- Hypomagnesemia
- Hypophosphatemia
- Uremia
Common Causes
Diagnosis
Shown below is an algorithm summarizing the diagnosis of [[disease name]] according to the American Academy of Neurology guidelines.
| Generalized weakness symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| True motor weakness? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Evaluate for causes of fatigue or muscle pain | Fluctuating | Constant | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| •Myasthenia Gravis •Lambert-Eaton syndrome •Periodic paralysis •Metabolic myopathy | Acquiered | Life-long/chronic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| •Polymyositis •Dematomyositis •Inclusion body myopathy •Amyotrophic lateral sclerosis •Multifocal motor neuropathy | Non-progessive | Progressive | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| •Congenital myopathy •Congenital dystrophy | Ocular •Kearns-sayre syndrome •Oculopharyngeal dystrophy •Ocular dystrophy | Facial •Fascioscapulohumarl dystrophy •Myotonic dystrophy | Upper extremities •Emery-Dreiffus dystrophy •Hereditary distal myopathy | Lower extremities •Duchenne's muscular dystrophy •Becker's muscular dystrophy •Sarcoglycanopathies •Spinal muscular atrophy •Limb girdle dystrophy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of [[disease name]] according to the [...] guidelines.
Do's
- The content in this section is in bullet points.
Don'ts
- The content in this section is in bullet points.